« Back
Home /
Trimetazidine dihydrochloride

Trimetazidine dihydrochloride

Item no.	M6037-50mg
Manufacturer	AbMole
CASRN	13171-25-0
Amount	50mg
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Heart & Blood Cancer
Type	Inhibitors
Specific against	other
Purity	0,9974
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	Yoshimilon, Kyurinett, Vastarel F
Available
Target Information	Others
Molecular Weight	339, 26
Solubility	67 mg/mL warmed in DMSO
Bioactivity information	Trimetazidine dihydrochloride is a kind of drug for treatment of chronic ischemic disorders. It improves myocardial glucose utilization through inhibition of fatty acid metabolism, known as fatty acid oxidation inhibitor.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

M6037-50mg-safety-datasheet.pdf